Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men

Journal of Clinical Investigation

Volumn 103, Issue 8, 1999, Pages 1191-1199

  Lamarche, Benoît ^a   Uffelman, Kristine D ^a   Carpentier, André ^a   Cohn, Jeffrey S ^b   Steiner, George ^a   Barrett, P Hugh ^c   Lewis, Gary F ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c University of Washington   (United States)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CATABOLISM; ENZYME ACTIVITY; ENZYME MODIFICATION; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN METABOLISM; METABOLIC CLEARANCE RATE; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT;

EID: 0033560938     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5286     Document Type: Article

References (42)

1. Miller, G.J., and Miller, N.E. 1977. Plasma high densitylipoprotein concentration and development of ischaemic heart disease. Lancet. 1:16-18.
2. Durrington, P.N. 1993. How HDL protects against acheroma. Lancet. 342:1315-1316.
3. Reichl, D., and Miller, N.E. 1989. Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arterioscler. Thromb. Vasc. Biol. 9:785-797.
4. Lamarche, B., et al. 1993. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler. Thromb. 13:33-40.
5. Brinton, E.A., Eisenberg, S., and Breslow, J.L. 1991. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87:536-544.
6. Nestel, P.J. 1987. High-density lipoproteins turnover. Am. Heart J. 113:518-521.
7. Brinton, E.A., Eisenberg, S., and Breslow, J.L. 1994. Human HDL cholesterol levels are determined by apoA-1 fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14:707-720.
8. Hayek, T., et al. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J. Clin. Invest. 92:1143-1152.
9. Rao, S.N., Magill, P.J., Miller, N.E., and Lewis, B. 1980. Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins AI and AII. Clin. Sci. 59:359-367.
10. Tall, A.R. 1995. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J. Intern. Med. 237:5-12.
11. Beisiegel, U. 1996. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis. 124:1-8.
12. Olivecrona, G., and Olivecrona, T. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6:291-305.
13. Horowitz, B.S., et al. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91:1743-1752.
14. Clay, M.A., Newnham, H.H., and Barter, P.J. 1991. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11:415-422.
15. Lewis, G.F., et al. 1997. Clearance of post-prandial and lipolytically modified human HDL in rabbits and rats. J. Lipid Res. 38:1771-1781.
16. Lamarche, B., Uffelman, K.D., Barrett, H.R., Steiner, G., and Lewis, G.F. 1998. Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. J. Lipid Res. 39:1162-1172.
17. Hayek, T., et al. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particles sizes, and metabolism. J. Clin. Invest. 92:1143-1152.
18. Melchior, G.W., et al. 1994. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels. J. Biol. Chem. 269:8044-8051.
19. Clay, M.A., Newnham, H.H., Forte, T.M., and Barter, P.J. 1992. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim. Biophys. Acta. 1124:52-58.
20. Goldberg, I.J., Blaner, W.S., Vanni, T.M., Moukides, M., and Ramakrishnan, R. 1990. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J. Clin. Invest. 86:463-473.
21. Mcfarlane, A.S. 1958. Efficient trace labeling of proteins with iodine. Nature. 182:53-57.
22. Li, Z., McNamaram, J.R., Ordovas, J.M., and Schaefer, E.J. 1994. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J. Lipid Res. 35:1698-1711.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193:265-275.
24. Myher, J.J., and Kuksis, A. 1984. Determination of plasma total lipid profiles by capillary gas-liquid chromatography. J. Biochem. Biophys. Methods. 10:13-23.
25. Kuksis, A., Myher, J.J., Marai, L., and Geher, K. 1975. Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis. J. Chromatogr. Sci. 13:423-430.
26. Pruzanski, W., et al. 1998. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J. Lipid Res. 39:2150-2160.
27. Cohn, J.S., et al. 1996. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16:149-159.
28. Fredenrich, A., et al. 1997. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid Res. 38:1421-1432.
29. Lewis, G.F., et al. 1990. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J. Clin. Endocrinol. Metab. 71:1041-1050.
30. Lewis, G.F., et al. 1991. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus (NIDDM) is an important predictor of postprandial lipid and lipoprotein abnormalties. J. Clin. Endocrinol. 72:934-944.
31. Davidson, W.S., Sparks, D.L., Lund-Katz, S., and Phillips, M.C. 1994. The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins. J. Biol. Chem. 269:8959-8965.
32. Miller, N.E. 1990. HDL metabolism and its role in lipid transport. Eur. Heart J. 11(Suppl.H):1-3.
33. Le, N.A., Gibson, J.C., and Ginsberg, H.N. 1988. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. J. Lipid Res. 29:669-677.
34. Rader, D.J., Castro, G., Zech, L.A., Fruchart, J.C., and Brewer, H.B., Jr. 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J. Lipid Res. 32:1849-1859.
35. Skinner, E.R. 1994. High-density lipoprotein subclasses. Curr. Opin. Lipidol. 5:241-247.
36. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25:1017-1058.
37. Zhong, S., et al. 1994, Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J. Clin. Invest. 94:2457-2467.
38. Murakami, T., et al. 1995. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15:1819-1828.
39. Ji, Z.S., Dichek, H.L., Miranda, R.D., and Mahley, R.W. 1997. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 272:31285-31292.
40. Champarnaud, G., Ouguerram, K., Magot, T., and Lutton, C. 1992. Overestimation of the lipoprotein fractional catabolic rate (FCR) measured in short duration experiments. J. Pharmacobiodyn. 15:541-546.
41. Vega, G.L., Gylling, H., Nichols, A.V., and Grundy, S.M. 1991. Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. J. Lipid Res. 32:867-875.
42. Schaefer, E.J., et al. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23:850-862.